Specialty doctors are lobbying Congress to exclude the cost of drugs they administer from the calculation of their Medicare bonuses and penalties because the therapies are often expensive and would result in volatile swings in reimbursement. At a minimum, doctors say, CMS should seek clarification from Congress before including Part B drugs in calculations of physician costs in the new physician pay system. The Quality Payment Program that determines physician pay has two tracks: Merit-based Incentive Payment System and alternative...